Epitopea Awarded Grant from Innovate UK’s Cancer Therapeutics Programme
Grant to advance development of Cryptigen immunotherapeutics for cancer
CAMBRIDGE, UK and MONTREAL, CANADA, 12 September 2024 – Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, announces it has been awarded a grant of just over £500,000 (approximately $658,000 USD) from Innovate UK.
